Abivax completes pre-NDA meeting with FDA for ulcerative colitis drug

Go back to Abivax completes pre-NDA meeting with FDA for ulcerative colitis drug
(NASDAQ: ABVX) Delayed: 90.23 --0 (-0%)
Previous Close $90.23    52 Week High $ 
Open $90.23    52 Week Low $ 
Day High $90.23    P/E N/A 
Day Low $90.23    EPS $ 
Volume 5,074